Vaccine Damage Payment Scheme: Coronavirus
(asked on 20th April 2023) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 April 2023 to Question 176541 on Vaccine Damage Payment Scheme: Coronavirus, which safety concerns relating to covid-19 vaccines have been the subject of advice for (a) healthcare professionals and (b) patients since January 2021.
Answered by
Maria Caulfield
Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The United Kingdom Health Security Agency (UKHSA) publishes a range of resources to support healthcare professionals delivering the COVID-19 vaccination programme. Information on vaccine safety is available in the green book (chapter 14a), the primary professional source of guidance for front line immunisers, available at the following link:
https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14ai
Information on adverse events is available at the following links:
https://www.gov.uk/government/collections/covid-19-vaccination-and-rare-side-effects
UKHSA also produces patient information leaflets, which include information on rare side effects following vaccination. ‘What to expect after your COVID-19 vaccine’ is available at the following link:
https://www.gov.uk/government/publications/covid-19-vaccination-what-to-expect-after-vaccination
Vaccine safety remains at the forefront of the COVID-19 vaccine programme. The Medicines and Healthcare products Regulatory Agency is responsible for monitoring the safety of all COVID-19 vaccines approved in the United Kingdom.